Virbac : Feedback webcast : S1 en avance sur la guidance et confiance du management sur le modèle et la capacité à délivrer
>Sérénité et visibilité affichée par le management - Lors de son webcast, le management a souligné les gains de parts de marché et sa surperformance régulière du marché vétérinaire. Nous retenons surtout :1/ La guidance 2024 est maintenue (MOP 24e :16%) malgré un S1 meilleure qu’attendu par le consensus : elle nous semble prudente comme indiqué hier matin (relire notre commentaire), mais le CFO a fait valoir une croissance moindre au S2 et la saisonnalité histori...Virbac is an independent veterinary pharmaceutical laboratory. Co. develops and provides veterinarians and farmers with medicines and vaccines that improve the health of food producing animals. Co. markets a range of products designed for pets and livestock. It offers seven types of products for companion animals (Parasiticides, Immunology, Antibiotics/dermatology, Specialties, Equine, Specialized pet food and Other products), and four types of products for food producing animals (Bovine parasiticides, Bovine products (excluding parasiticides), Pig/poultry antibiotics and Other products). Co. markets its products in the ethical (veterinarian) and OTC markets.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.